131 related articles for article (PubMed ID: 37696386)
1. Accumulation of advanced glycation end products promotes atrophic nonunion incidence in mice through a CtBP1/2-dependent mechanism.
Chen X; Wang C; Zhou D; Zhao G; Li Z; Duan N
Exp Cell Res; 2023 Nov; 432(1):113765. PubMed ID: 37696386
[TBL] [Abstract][Full Text] [Related]
2. Suppression of DNMT2/3 by proinflammatory cytokines inhibits CtBP1/2-dependent genes to promote the occurrence of atrophic nonunion.
Chen X; Wang C; Zhao G; Li Z; Zhang W; Song T; Zhang C; Duan N
Cytokine; 2024 Jan; 173():156436. PubMed ID: 37979214
[TBL] [Abstract][Full Text] [Related]
3. The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional complex.
Zhang W; Duan N; Zhang Q; Song T; Li Z; Chen X; Wang K
Int J Biol Sci; 2018; 14(14):2023-2036. PubMed ID: 30585266
[TBL] [Abstract][Full Text] [Related]
4. NSM00158 Specifically Disrupts the CtBP2-p300 Interaction to Reverse CtBP2-Mediated Transrepression and Prevent the Occurrence of Nonunion.
Chen X; Zhang W; Zhang Q; Song T; Yu Z; Li Z; Duan N; Dang X
Mol Cells; 2020 Jun; 43(6):517-529. PubMed ID: 32434298
[TBL] [Abstract][Full Text] [Related]
5. Methylglyoxal - an advanced glycation end products (AGEs) precursor - Inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE).
Waqas K; Muller M; Koedam M; El Kadi Y; Zillikens MC; van der Eerden BCJ
Bone; 2022 Nov; 164():116526. PubMed ID: 35995334
[TBL] [Abstract][Full Text] [Related]
6. AGEs-RAGE axis mediates myocardial fibrosis via activation of cardiac fibroblasts induced by autophagy in heart failure.
Liang B; Zhou Z; Yang Z; Liu J; Zhang L; He J; Li H; Huang Y; Yang Q; Xian S; Wang L
Exp Physiol; 2022 Aug; 107(8):879-891. PubMed ID: 35598104
[TBL] [Abstract][Full Text] [Related]
7. Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.
Lin CP; Huang PH; Chen CY; Wu MY; Chen JS; Chen JW; Lin SJ
Sci Rep; 2021 Sep; 11(1):17851. PubMed ID: 34497344
[TBL] [Abstract][Full Text] [Related]
8. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
Phimphilai M; Pothacharoen P; Kongtawelert P
Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
[TBL] [Abstract][Full Text] [Related]
9. The advanced glycation end-product N
Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
[TBL] [Abstract][Full Text] [Related]
10. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.
Kuppuswamy M; Vijayalingam S; Zhao LJ; Zhou Y; Subramanian T; Ryerse J; Chinnadurai G
Mol Cell Biol; 2008 Jan; 28(1):269-81. PubMed ID: 17967884
[TBL] [Abstract][Full Text] [Related]
11. Receptor for advanced glycation end products modulates oxidative stress and mitochondrial function in the soleus muscle of mice fed a high-fat diet.
Velayoudom-Cephise FL; Cano-Sanchez M; Bercion S; Tessier F; Yu Y; Boulanger E; Neviere R
Appl Physiol Nutr Metab; 2020 Oct; 45(10):1107-1117. PubMed ID: 32289236
[TBL] [Abstract][Full Text] [Related]
12. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway.
Meng HZ; Zhang WL; Liu F; Yang MW
J Biol Chem; 2015 Nov; 290(47):28189-28199. PubMed ID: 26472922
[TBL] [Abstract][Full Text] [Related]
14. Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway.
Cheng YZ; Yang SL; Wang JY; Ye M; Zhuo XY; Wang LT; Chen H; Zhang H; Yang L
Life Sci; 2018 Jul; 205():184-192. PubMed ID: 29702126
[TBL] [Abstract][Full Text] [Related]
15. Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS.
Azhary JMK; Harada M; Kunitomi C; Kusamoto A; Takahashi N; Nose E; Oi N; Wada-Hiraike O; Urata Y; Hirata T; Hirota Y; Koga K; Fujii T; Osuga Y
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 32020188
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice.
Li P; Tang Z; Wang L; Feng B
Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911
[TBL] [Abstract][Full Text] [Related]
17. Advanced Glycation End Products, Diabetes, and Bone Strength.
Yamamoto M; Sugimoto T
Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
[TBL] [Abstract][Full Text] [Related]
18. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
[TBL] [Abstract][Full Text] [Related]
19. The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma.
Chen X; Zhang Q; Dang X; Fan J; Song T; Li Z; Duan N; Zhang W
Transl Oncol; 2022 Jul; 21():101429. PubMed ID: 35452995
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts.
Franke S; Siggelkow H; Wolf G; Hein G
Arch Physiol Biochem; 2007 Jun; 113(3):154-61. PubMed ID: 17922311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
